scorecardresearch
Monday, August 11, 2025
Support Our Journalism
HomeIndiaAIIMS-Bhubaneswar set to be accorded CoE status for management, research of sickle...

AIIMS-Bhubaneswar set to be accorded CoE status for management, research of sickle cell disease

Follow Us :
Text Size:

Bhubaneswar, Jun 19 (PTI) AIIMS-Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for the management and research of sickle cell disease, Union minister Jual Oram said on Thursday.

Oram, while addressing an event organised on the occasion of World Sickle Cell Awareness Day here, highlighted the pivotal role played by the institute in delivering comprehensive care to sickle cell patients in Odisha and neighbouring states.

“The Centre of Excellence tag will further strengthen AIIMS-Bhubaneswar’s capabilities in advanced research and quality treatment of sickle cell disease,” he stated.

Sickle cell disease is a group of inherited blood disorders, doctors said.

The central government is committed to eradicating sickle cell anaemia by 2047. So far, 5.79 crore people have been screened across the country, the Union Tribal Affairs Minister said.

Among them, 5.55 crore have tested negative, 16.38 lakh have been identified as carriers, and 2.10 lakh diagnosed with the disease, Oram said.

AIIMS-Bhubaneswar has thus far treated more than 700 sickle cell patients, and over 500 of them are in the 0–19 age group, officials said.

Oram also toured various facilities of the institute and interacted with sickle cell patients and their family members.

Besides, the minister participated in a review meeting and a scientific session focused on sickle cell disease. PTI BBM RBT

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular